COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.

Saved in:
Bibliographic Details
Main Authors LUCAS, Brian S, PARAS, Nick A
Format Patent
LanguageEnglish
Published 11.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
Bibliography:Application Number: US202017075864